PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10001269::ACT000016

AGPAGPAGPAGPR

Evidence text

Paper-level observation

Table 3: ACE IC50 Seq5 (AGPAGPAGPAGPR) 11.7 ± 1.34 mM.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
other
Comparator
=
Raw observation
11.7 ± 1.34 other
Normalized measurement
=11.7 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Oryctolagus cuniculus
Assay method
Not reported by source
Sequence
AGPAGPAGPAGPR
Standardization
ready simple

Source publication

The Bioaccessibility of Yak Bone Collagen Hydrolysates: Focus on Analyzing the Variation Regular of Peptides and Free Amino Acids

Foods · 2023

DOI 10.3390/foods12051003 PMC10001269
Parent mention

Related peptide identities

PEPDIA-PLP-000095

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.